Importance of worldwide research of the patients with dermatomyositis/ polymyositis
DOI:
https://doi.org/10.66344/jpad.34.2.2024.2568Keywords:
Worldwide research, Dermatomyositis, PolymyositisReferences
Sasaki H, Kohsaka H. Current diagnosis and treatment of polymyositis and dermatomyositis. Vol. 28, Modern Rheumatology. Taylor and Francis Ltd; 2018. p. 913–21.
DeWane ME, Waldman R, Lu J. Dermatomyositis: Clinical features and pathogenesis. J Am Acad Dermatol. 2020;82:267–81.
Bernal-MacÃas S, Fernández-Ãvila DG, Rincón-Riaño DN, Gutiérrez JM, Rosselli D. Prevalence of inflammatory myopathies in Colombia: Demographic analysis from the National Health Registry 2012–2018. Revista Colombiana de Reumatologia. 2021;
Inés L, Casas P, Johanna A, Tolosa A, Lilian E, Rodriguez Gutiérrez A, et al. MarÃa Andrea Godoy Casadiego Viceministro de Protección Social.
Santos VA, Aragón CC, Posso-Osorio I, Obando MA, Barrera T, Zamorano L, et al. Epidemiological characterization of patients with inflammatory myopathy in a fourth level hospital in Cali, Colombia. Revista Colombiana de Reumatologia. 2021;28(2):83–8.
Obando-Valencia CR, Merchán-Galvis ÃM. Polimiositis: evolución de 4 años y agudización en 2019, caso masculino en Popayán, Cauca. Revista Médicas UIS. 2022;35(1).
Liao J, Peng X, Liu J, Xie X, Wang J. The efficacy and safety of tacrolimus in patients with dermatomyositis/ polymyositis: A meta-analysis and systematic review. Eur J Intern Med. 2023 Jan; Available from: https://linkinghub.elsevier.com/retrieve/pii/S0953620523000249
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.